Core Viewpoint - A securities class action lawsuit has been filed against ICON Public Limited Company for allegedly making materially false and misleading statements regarding its business operations and financial health during the class period from July 27, 2023, to October 23, 2024 [1]. Allegations of Misconduct - The lawsuit claims that ICON suffered a significant loss of business due to customer cost reduction measures and funding limitations affecting its client base [3]. - ICON's hybrid model offerings were reportedly insufficient to mitigate the adverse effects of a market downturn [3]. - Requests for proposals from biotechnology customers were primarily used for price discovery rather than indicating actual client demand [3]. - Customers canceled contracts, reduced engagements, and delayed clinical trial work, impacting ICON's ability to secure new contracts at historical rates [3]. - Two of ICON's largest customers began diversifying their service providers away from the company [3]. - As a result of these issues, ICON's reported net new business awards and book-to-bill metrics misrepresented actual client demand [3]. - Positive statements made by ICON regarding its business and prospects were deemed materially misleading and lacked a reasonable basis [3]. Lead Plaintiff Process - Investors in ICON have until April 11, 2025, to seek appointment as a lead plaintiff representative of the class or may choose to remain absent [4]. - The lead plaintiff will represent all class members in directing the litigation and is typically the investor or group of investors with the largest financial interest [4]. - The lead plaintiff has the authority to select counsel to represent the class, subject to court approval [4].

NEW YORK, March 18, 2025 /PRNewswire/ -- Levi & Korsinsky, LLP notifies investors in ICON Public Limited Company ("ICON " or the "Company") (NASDAQ: ICLR) of a class action securities lawsuit.CLASS DEFINITION: The lawsuit seeks to recover losses on behalf of ICON investors who were adversely affected by alleged securities fraud between July 27, 2023 and October 23, 2024. Follow the link below to get more information and be contacted by a member of our team:https://zlk.com/pslra-1/icon-public-limited-company ...

NEW YORK, March 17, 2025 /PRNewswire/ -- The Gross Law Firm issues the following notice to shareholders of ICON Public Limited Company (NASDAQ: ICLR).Shareholders who purchased shares of ICLR during the class period listed are encouraged to contact the firm regarding possible lead plaintiff appointment. Appointment as lead plaintiff is not required to partake in any recovery.CONTACT US HERE:https://securitiesclasslaw.com/securities/icon-public-limited-company-loss-submission-form/?id=136013&from=4 CLASS PER ...

Core Viewpoint - A securities class action lawsuit has been filed against ICON Public Limited Company for allegedly making materially false and misleading statements regarding its business operations and financial health during the Class Period from July 27, 2023, to October 23, 2024 [1]. Group 1: Allegations Against ICON - The lawsuit claims that ICON suffered a material loss of business due to customer cost reduction measures and funding limitations impacting its client base [2]. - It is alleged that ICON's hybrid model offerings were inadequate to protect the company from a significant market downturn [2]. - The requests for proposals from biotechnology customers were reportedly used as price discovery tools rather than indicative of actual client demand [2]. - Customers of ICON are said to have canceled contracts, limited engagements, delayed clinical trial work, and failed to enter into new contracts at historical rates [2]. - The two largest customers of ICON were diversifying their providers away from the company [2]. - As a result of these issues, ICON's reported net new business awards and book-to-bill metrics allegedly misrepresented actual client demand for its services [2]. - Positive statements made by ICON regarding its business and prospects were claimed to be materially misleading and lacked a reasonable basis [2]. Group 2: Lead Plaintiff Process - ICON investors have until April 11, 2025, to seek appointment as a lead plaintiff representative of the class through Kessler Topaz Meltzer & Check, LLP or other counsel [3]. - A lead plaintiff acts on behalf of all class members and is typically the investor or small group of investors with the largest financial interest [3]. - The decision to serve as a lead plaintiff does not affect an investor's ability to share in any recovery [3]. Group 3: Firm Information - Kessler Topaz Meltzer & Check, LLP is known for prosecuting class actions and has recovered billions for victims of corporate misconduct [4]. - The firm aims to protect investors and others from fraud and negligence by businesses [4].

NEW YORK, March 10, 2025 /PRNewswire/ -- The Gross Law Firm issues the following notice to shareholders of ICON Public Limited Company (NASDAQ: ICLR).Shareholders who purchased shares of ICLR during the class period listed are encouraged to contact the firm regarding possible lead plaintiff appointment. Appointment as lead plaintiff is not required to partake in any recovery.CONTACT US HERE:https://securitiesclasslaw.com/securities/icon-public-limited-company-loss-submission-form/?id=134601&from=4CLASS PERI ...

Core Viewpoint - A class action securities lawsuit has been filed against ICON Public Limited Company, alleging securities fraud that negatively impacted investors between July 27, 2023, and October 23, 2024 [1][2]. Group 1: Allegations of Fraud - The lawsuit claims that ICON suffered a material loss of business due to customer cost reduction measures and funding limitations affecting its client base [2]. - It is alleged that ICON's service offerings were inadequate to protect the company from a significant market downturn [2]. - The requests for proposals from biotechnology customers were reportedly used as price discovery tools, not reflecting actual client demand [2]. - Customers of ICON are said to have canceled contracts, limited engagements, and delayed clinical trial work, impacting new contracts at historical rates [2]. - The two largest customers of ICON were diversifying their clinical research organization providers away from the company [2]. - As a result of these issues, ICON's reported business metrics misrepresented actual client demand for its services [2]. - The company was tracking significantly below its 2024 revenue and EPS guidance, which lacked a reasonable factual basis [2]. Group 2: Legal Process and Participation - Investors who suffered losses in ICON during the specified period have until April 11, 2025, to request appointment as lead plaintiff [3]. - Class members may be entitled to compensation without any out-of-pocket costs or fees [3]. Group 3: Firm Background - Levi & Korsinsky has a history of securing substantial settlements for shareholders and is recognized as a leading firm in securities litigation [4].

Core Viewpoint - A securities class action lawsuit has been filed against ICON Public Limited Company for allegedly making materially false and misleading statements regarding its business operations and financial health during the Class Period from July 27, 2023, to October 23, 2024 [1]. Group 1: Allegations Against ICON - The lawsuit claims that ICON suffered a material loss of business due to customer cost reduction measures and funding limitations impacting its client base [2]. - It is alleged that ICON's hybrid model offerings were inadequate to protect the company from a significant market downturn [2]. - The requests for proposals from biotechnology customers were reportedly used as price discovery tools rather than indicative of actual client demand [2]. - Customers of ICON are said to have canceled contracts, limited engagements, delayed clinical trial work, and failed to enter into new contracts at historical rates [2]. - The two largest customers of ICON were diversifying their providers away from the company [2]. - As a result of these issues, ICON's reported net new business awards and book-to-bill metrics allegedly misrepresented actual client demand [2]. - Positive statements made by ICON regarding its business and prospects were claimed to be materially misleading and lacked a reasonable basis [2]. Group 2: Lead Plaintiff Process - ICON investors have until April 11, 2025, to seek appointment as a lead plaintiff representative of the class through Kessler Topaz Meltzer & Check, LLP or other counsel [3]. - A lead plaintiff acts on behalf of all class members and is typically the investor or small group of investors with the largest financial interest [3]. - The decision to serve as a lead plaintiff does not affect an investor's ability to share in any recovery [3]. Group 3: Firm Information - Kessler Topaz Meltzer & Check, LLP is known for prosecuting class actions and has recovered billions for victims of corporate misconduct [4]. - The firm aims to protect investors and others from fraud and negligence by businesses [4].

NEW YORK, March 06, 2025 (GLOBE NEWSWIRE) -- The Gross Law Firm issues the following notice to shareholders of ICON Public Limited Company (NASDAQ: ICLR). Shareholders who purchased shares of ICLR during the class period listed are encouraged to contact the firm regarding possible lead plaintiff appointment. Appointment as lead plaintiff is not required to partake in any recovery. CONTACT US HERE: https://securitiesclasslaw.com/securities/icon-public-limited-company-loss-submission-form/?id=134072&from=3 CL ...

NEW YORK, March 6, 2025 /PRNewswire/ -- The Gross Law Firm issues the following notice to shareholders of ICON Public Limited Company (NASDAQ: ICLR).Shareholders who purchased shares of ICLR during the class period listed are encouraged to contact the firm regarding possible lead plaintiff appointment. Appointment as lead plaintiff is not required to partake in any recovery.CONTACT US HERE:https://securitiesclasslaw.com/securities/icon-public-limited-company-loss-submission-form/?id=134051&from=4CLASS PERIO ...

BERWYN, Pa.  and DUBLIN, March 4, 2025 /PRNewswire/ -- Mural Health Technologies, Inc., a patient-first clinical trial technology company, and ICON plc (NASDAQ: ICLR), a global healthcare intelligence and clinical research organization, today announce a partnership to utilize the participant management and payments platform, Mural Link. ICON will utilize Mural Link's innovative functionality related to clinical trial participant payments, tax management, travel and concierge support, site-participant commun ...